Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial

Autor: Hung, Ivan Fan-Ngai, Zhang, Anna Jinxia, To, Kelvin Kai-Wang, Chan, Jasper Fuk-Woo, Li, Patrick, Wong, Tin-Lun, Zhang, Ricky, Chan, Tuen-Ching, Chan, Brian Chun-Yuan, Wai, Harrison Ho, Chan, Lok-Wun, Fong, Hugo Pak-Yiu, Hui, Raymond Kar-Ching, Kong, Ka-Lun, Leung, Arthur Chun-Fung, Ngan, Abe Ho-Ting, Tsang, Louise Wing-Ki, Yeung, Alex Pat-Chung, Yiu, Geo Chi-Ngo, Yung, Wing, Lau, Johnson Y-N, Chen, Honglin, Chan, Kwok-Hung, Yuen, Kwok-Yung
Zdroj: In The Lancet Infectious Diseases February 2016 16(2):209-218
Databáze: ScienceDirect